EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C21H30O2 |
| Net Charge | 0 |
| Average Mass | 314.469 |
| Monoisotopic Mass | 314.22458 |
| SMILES | [H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)Oc1cc(CCCCC)cc(O)c12 |
| InChI | InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1 |
| InChIKey | CYQFCXCEBYINGO-IAGOWNOFSA-N |
| Wikipedia |
|---|
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Cannabis sativa (ncbitaxon:3483) | aerial part (BTO:0001658) | PubMed (21902175) | Acetone extract of Dried, powdered and heated flowered aerial parts |
| Roles Classification |
|---|
| Biological Roles: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. non-narcotic analgesic A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. epitope The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds. cannabinoid receptor agonist An agonist that binds to and activates cannabinoid receptors. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. cannabinoid receptor agonist An agonist that binds to and activates cannabinoid receptors. cannabinoid receptor agonist An agonist that binds to and activates cannabinoid receptors. |
| Applications: | hallucinogen Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations and other alterations of mood and thinking. non-narcotic analgesic A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role cannabinoid receptor agonist (CHEBI:67072) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role epitope (CHEBI:53000) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role hallucinogen (CHEBI:35499) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role metabolite (CHEBI:25212) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role non-narcotic analgesic (CHEBI:35481) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) is a benzochromene (CHEBI:38920) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) is a diterpenoid (CHEBI:23849) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) is a phytocannabinoid (CHEBI:67196) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) is a polyketide (CHEBI:26188) |
| Incoming Relation(s) |
| 11-hydroxy-Δ9-tetrahydrocannabinol (CHEBI:77270) has functional parent Δ9-tetrahydrocannabinol (CHEBI:66964) |
| 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (CHEBI:77273) has functional parent Δ9-tetrahydrocannabinol (CHEBI:66964) |
| IUPAC Name |
|---|
| (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol |
| INN | Source |
|---|---|
| dronabinol | KEGG DRUG |
| Synonyms | Source |
|---|---|
| Dronabinol | KEGG COMPOUND |
| delta9-Tetrahydrocannabinol | KEGG COMPOUND |
| Tetrahydrocannabinol | KEGG COMPOUND |
| Δ1-tetrahydrocannabinol | SUBMITTER |
| Δ9-THC | SUBMITTER |
| Dronabinolum | ChemIDplus |
| Brand Name | Source |
|---|---|
| Syndros | ChEBI |
| UniProt Name | Source |
|---|---|
| Δ9-tetrahydrocannabinol | UniProt |
| Manual Xrefs | Databases |
|---|---|
| C06972 | KEGG COMPOUND |
| CPD-7172 | MetaCyc |
| TCI | PDBeChem |
| D00306 | KEGG DRUG |
| DB00470 | DrugBank |
| Tetrahydrocannabinol | Wikipedia |
| HMDB0041865 | HMDB |
| C00002675 | KNApSAcK |
| 4109 | DrugCentral |
| Citations |
|---|